REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Yili Chuanning Biotechnology Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Yili Chuanning Biotechnology Co.,Ltd Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Yili Chuanning Biotechnology Co., Ltd. is engaged in the R&D and industrialization of biological fermentation technology. The company’s main products include erythromycin thiocyanate, cephalosporin intermediates, Penicillin G Potassium, Ursodeoxycholic Acid. The company was established in 2010 and is headquartered in Yili City, Xinjiang Province.

Headquarters
No. 1, Gongchen Road, Yining Park, Khorgos Economic Development Zone, Ili Kazakh Autonomous Prefecture, Xinjiang Uygur Autonomous Region
Ili; Xinjiang; Postal Code: 835000

Contact Details: Purchase the Yili Chuanning Biotechnology Co.,Ltd report to view the information.

Website: http://www.klcnsw.com

Basic Information
Total Employees:
Purchase the Yili Chuanning Biotechnology Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Yili Chuanning Biotechnology Co.,Ltd report to view the information.
Registered Capital:
Purchase the Yili Chuanning Biotechnology Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Yili Chuanning Biotechnology Co.,Ltd report to view the information.
Incorporation Date:
December 10, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
70.63%
Purchase this report to view the information.
4.35%
Purchase this report to view the information.
3.2%
Purchase this report to view the information.
2.36%
Purchase this report to view the information.
2.1%
Subsidiaries
Horgos Jinhe Biotechnology Co., Ltd.
100%
Horgos Yinghui Trading Co., Ltd.
100%
Shanghai Ruikang Biotechnology R&D Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Yili Chuanning Biotechnology Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
19.96%▲
Total operating revenue
19.96%▲
Operating profit (EBIT)
98.48%▲
EBITDA
113.78%▲
Net Profit (Loss) for the Period
100.99%▲
Total assets
4.55%▲
Total equity
14.83%▲
Operating Profit Margin (ROS)
11%▲
Net Profit Margin
9.33%▲
Return on Equity (ROE)
2.06%▲
Debt to Equity Ratio
-11.62%▼
Quick Ratio
-0.04%▼
Cash Ratio
-0.06%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shanxi Zhendong Pharmaceutical Co.,Ltd
 
Tianjin Tianyao Pharmaceuticals Co.,Ltd
Dingdang Health Technology Group Limited
 
Porton Pharma Solutions Ltd.
Giant Biogene Holding Company Limited
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo